Drug firm Glenmark Pharmaceuticals, under the brand name FabiFlu, has launched an antiviral drug Favipiravir, to cure patients with mild to moderate coronavirus at a price tag of about Rs 103 per tablet.
According to Glenmark Pharmaceuticals, the medication will be available in the form of a 200 mg tablet and will be at a maximum retail price (MRP) of Rs 3,500 for a strip of 34 tablets.
” With over 14,800 new cases reported in the last 24 hours, India’s COVID-19 count on Monday crossed the 4.25 lakh-mark, while the death toll has almost touched the 13,700-mark as well “
